PDT Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-43,439
Closed -$5.45M 942
2020
Q4
$5.45M Sell
43,439
-8,961
-17% -$1M 0.37% 95
2020
Q3
$5.32M Sell
52,400
-3,963
-7% -$404K 0.35% 118
2020
Q2
$5.48M Sell
56,363
-18,358
-25% -$1.71M 0.37% 108
2020
Q1
$6.21M Buy
74,721
+68,836
+1,170% +$6.71M 0.49% 68
2019
Q4
$654K Buy
+5,885
New +$605K 0.04% 364
2017
Q4
Sell
-113,963
Closed -$8.68M 580
2017
Q3
$8.68M Buy
113,963
+41,163
+57% +$3.11M 0.29% 126
2017
Q2
$5.46M Sell
72,800
-333
-0.5% -$23.1K 0.22% 150
2017
Q1
$4.77M Sell
73,133
-10,967
-13% -$646K 0.25% 148
2016
Q4
$4.64M Sell
84,100
-1,100
-1% -$60.4K 0.3% 152
2016
Q3
$4.82M Buy
85,200
+26,800
+46% +$1.31M 0.28% 147
2016
Q2
$2.44M Buy
+58,400
New +$2.69M 0.19% 179
2015
Q3
Sell
-12,472
Closed -$453K 1682
2015
Q2
$453K Sell
12,472
-20,414
-62% -$646K 0.01% 1006
2015
Q1
$948K Buy
+32,886
New +$917K 0.02% 810

Other funds holding PRAH

PDT Partners's PRAH Position: Q1 2021 in Review

PDT Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 43,439 shares — an estimated $5.45M sold.

PDT Partners first reported a position in PRAH in Q1 2015 and held it in 13 quarters. The position peaked at $8.68M in Q3 2017. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • PDT Partners reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • PDT Partners sold 43,439 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $5.45M.
  • PDT Partners first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 13 quarters.
  • PDT Partners's PRA Health Sciences, Inc. position peaked at $8.68M in Q3 2017.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on PDT Partners's 13F filing for Q1 2021, filed 17 May 2021.